Diagnostic accuracy of combined dipyridamole stress perfusion and delayed enhancement cardiovascular magnetic resonance imaging for detection of coronary artery disease

1. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002.10.1161/01.CIR.100.19.1992Search in Google Scholar

2. Klem I, Heitner JF, Shah DJ, Sketch MH Jr, Behar V, Weinsaft J, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement imaging. J Am Coll Cardiol. 2006; 47:1630-8.10.1016/j.jacc.2005.10.074Search in Google Scholar

3. Takase B, Nagata M, Kihara T, Kameyawa A, Noya K, Matsui T, et al. Whole-heart dipyridamole MRI for the detection of coronary artery disease stress first-pass myocardial perfusion. Jpn Heart J. 2004; 45:475-86.10.1536/jhj.45.475Open DOISearch in Google Scholar

4. Sakuma H, Suzawa N, Ichikawa Y, Makino K, Hirano T, Kitagawa K. Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy. Am J Roentgenol. 2005; 185:95-102.10.2214/ajr.185.1.01850095Search in Google Scholar

5. Cury RC, Cattani CA, Gabure LA, Racy DJ, de Gois JM, Siebert U, et al. Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease. Radiology. 2006; 240:39-45.10.1148/radiol.2401051161Search in Google Scholar

6. Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L, et al. Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J Cardiovasc Magn Reson. 2008; 10:18.10.1186/1532-429X-10-18Search in Google Scholar

7. Tumkosit M, Puntawangkoon C, Morgan TM, Clark HP, Hamilton CA, Ntim WO, et al. Leftventricular infarct size assessed with 0.1 mmol/kg ofgadobenate dimeglumine correlates with that assessed with 0.2 mmol/kg of gadopentetate dimeglumine. J Comput Assist Tomogr. 2009; 33:328-33.10.1097/RCT.0b013e318187fed0Search in Google Scholar

8. Gibbons RJ, Balady GJ, Bricker JT. Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2002; 40:1531-40.10.1016/S0735-1097(02)02164-2Search in Google Scholar

9. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002; 105:539-42.10.1161/hc0402.102975Search in Google Scholar

10. Schuijf JD, Poldermans D, Shaw LJ. Jukema JW, Lamb HJ, de Roos A, et al. Diagnostic and prognostic value of noninvasive imaging in known or suspected coronary artery disease. Eur J Nuc Med Mol Imaging. 2006; 33:93-104.10.1007/s00259-005-1965-ySearch in Google Scholar

11. Lee VS, Resnick D, Tiu SS, Sanger JJ, Nazzaro CA, Israel GM, et al. MR imaging evaluation of myocardial viability in the setting of equivocal SPECT results with 99mTc sestamibi. Radiology. 2004; 230:191-7.10.1148/radiol.2301030070Search in Google Scholar

12. Bodi V, Sanchis J, Lopez-Lereu MP, Nunez J, Mainar L, Monmeneu JV, et al. Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischemic cascade. Heart. 2009; 95:49-55.10.1136/hrt.2007.139683Search in Google Scholar

13. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular resonance imaging. N Engl J Med. 2002; 346:1948-53.10.1056/NEJMoa012369Search in Google Scholar

14. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast enhancedmagnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000; 343:1445-3.10.1056/NEJM200011163432003Search in Google Scholar

15. Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, Magnetic resonance perfusion measurement for the noninvasive detection of coronary artery disease. Circulation. 2003; 108:432-7.10.1161/01.CIR.0000080915.35024.A9Search in Google Scholar

16. Taylor AJ, Al-Saadi N, Abdel-Aty H, Schulz- MengerJ, Messroghli MG, Friedrich MG. Detection of acutely impaired microvascular reperfusion after infarctangioplasty with magnetic resonance imaging. Circulation. 2004; 109:2080-5.10.1161/01.CIR.0000127812.62277.50Search in Google Scholar